Results 31 to 40 of about 17,506 (246)

Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer. [PDF]

open access: yes, 2013
Peer ...
Bell   +73 more
core   +1 more source

Bilateral Primary Papillary Serous Carcinoma of the Fallopian Tube [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Primary fallopian tube carcinoma is considered one of the rarest female genital cancers, and its bilateral occurrence is even rarer. Because of the rarity of fallopian tube carcinomas as well as the clinical presentation which simulates an ovarian ...
H.K. Manjunatha   +2 more
doaj   +1 more source

Emerging Therapeutic Concepts and Latest Diagnostic Advancements Regarding Neuroendocrine Tumors of the Gynecologic Tract

open access: yesMedicina, 2021
Neuroendocrine neoplasms (NENs) are particularly rare in all sites of the gynecological tract and include a variety of neoplasms with variable prognosis, dependent on histologic subtype and site of origin.
Tiberiu-Augustin Georgescu   +10 more
doaj   +1 more source

Serous Cystadenocarcinoma with Fibroma of left ovary and epithelial dysplasia of left fallopian tube - A Case report

open access: yesJournal of Clinical and Biomedical Sciences, 2020
Collision tumors are best considered as separate primary neoplasms. These tumors have been reported in various organs, such as the esophagus, stomach, liver, thyroid gland, ovary, and lung, but they are extremely rare in the ovaries.
Preeti Utnal, Supreetha MS, Sheela S R
doaj   +1 more source

Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer – a case report with literature review

open access: yesMenopause Review, 2021
Pseudomyxoma peritonei (PMP) is a rare and uncommon condition, characterized by the presence of mucinous ascites in the abdominal cavity. The most common cause of PMP is mucinous adenocarcinoma of the appendix, followed by neoplasms of the ovary ...
Stoyan Kostov   +6 more
doaj   +1 more source

Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis [PDF]

open access: yes, 2012
Familial adenomatous polyposis (FAP) is an autosomal dominant cancer predisposition syndrome that accounts for approximately 0.5–1% of all colorectal cancer cases.
Abraham   +36 more
core   +1 more source

Wollfian tumor: a case report and a literature review

open access: yesAlʹmanah Kliničeskoj Mediciny, 2018
Wolffian tumor is a rare neoplasm arising from mesonephric duct remnants. Not more than 100 cases of the disease have been described. The authors present their own clinical observation of the Wolffian tumor in a 43-year old female patient.
E. A. Dubova   +5 more
doaj   +1 more source

Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment [PDF]

open access: yes, 2016
Background: Despite standard treatment for epithelial ovarian cancer (EOC), that involves cytoreductive surgery followed by platinum-based chemotherapy, and initial high response rates to these, up to 80 % of patients experience relapses with a median ...
Caruso, Davide   +4 more
core   +2 more sources

Ovarian mucinous borderline tumor with anaplastic carcinomatous nodules in adolescents

open access: yesJournal of Ovarian Research, 2022
Bilateral ovarian epithelial neoplasms in adolescents are rare. Moreover, borderline mucinous neoplasms with local intraepithelial carcinoma with anaplastic carcinoma are even more infrequent.
Mengqi Huang, Qian Lv, Jingyan Xie
doaj   +1 more source

Natural killer (NK) cells and their involvement in different types of cancer. Current status of clinical research [PDF]

open access: yes, 2017
Natural killer cells are the main agents of innate immunity. Since 1970, various studies have repeatedly confirmed their involvement in decreasing local tumor growth and also decreasing the risk of metastasis, due to their cytotoxic effects and also ...
Moldovan, Adina D.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy